Suggestions
Michael Chung
Chair, Department of Medicine
Professional Background
Dr. Michael Chung is a distinguished expert in the field of infectious diseases, with a specialized focus on HIV research in Kenya. With over 15 years of experience, he has established himself as a leader in the domain of HIV treatment and care. Currently, he holds the prestigious position of Chair and Professor in the Department of Medicine at Aga Khan University East Africa (AKU), located in Nairobi, Kenya. His commitment to improving the health outcomes of HIV-infected individuals is evident through his extensive research, clinical trials, and educational initiatives.
In 2004, Dr. Chung co-founded the Coptic Hope Center for Infectious Diseases, which stands as one of the largest single-site HIV treatment centers in Kenya. Under his guidance, the center has become a beacon of hope for many individuals living with HIV, providing compassionate care and innovative treatment strategies. His leadership extends to various funded efforts from the CDC and NIH aimed at enhancing the care and treatment of those affected by HIV, pushing the boundaries of medical knowledge through research training and online education.
Dr. Chung is the visionary behind the Treatment, Research, and Expert Education (TREE) program, renowned for its rigorous implementation of randomized clinical trials. He has spearheaded groundbreaking studies examining the effectiveness of new laboratory tests and therapies, focusing on significant issues such as pre-treatment HIV drug resistance. His work includes novel approaches to antiretroviral therapy (ART) and comparative studies on cryotherapy and loop electrosurgical excision procedures (LEEP) for treating pre-cancerous cervical lesions among HIV-positive women. Recently, Dr. Chung's research efforts have turned to understanding the chronic lung disease mechanisms among HIV-infected adolescents, highlighting his holistic approach to HIV care.
Education and Achievements
Dr. Chung's academic journey is a testament to his dedication and passion for the field of medicine. He completed his undergraduate studies with a Bachelor of Arts in Biology and English at Oberlin College. He continued on to the University of Chicago, earning his Medical Doctor (MD) degree at the esteemed Pritzker School of Medicine. His commitment to understanding public health issues led him to pursue a Master of Public Health (MPH) with a focus on International Health at the Harvard T.H. Chan School of Public Health. Dr. Chung's training further solidified at Harvard Medical School, where he completed his Internal Medicine Internship and Residency at Beth Israel Deaconess Medical Center.
Moreover, Dr. Chung holds a Doctor of Philosophy (PhD) in Health Services/Allied Health/Health Sciences from UGent. His diverse educational background equips him with a unique blend of clinical and public health expertise, enabling him to approach complex health challenges from multiple angles.
Professional Affiliations
As a testament to his expertise and the respect he commands in the academic community, Dr. Chung has held several notable positions throughout his career. He has served as an Affiliate Professor at the University of Washington, contributing to the academic growth of the next generation of medical professionals. Prior roles include Chairman of the Department of Medicine at Aga Khan University, Associate Professor, Assistant Professor, and Acting Instructor at the University of Washington, as well as a Visiting Research Scientist at the University of Nairobi.
His commitment to excellence and continuous learning is reflected in his various fellowships and internships, including a Residency at Beth Israel Deaconess Medical Center. Dr. Chung's professional journey showcases a rich tapestry of experience that informs his current research and educational efforts.
Achievements
- Co-founded the Coptic Hope Center for Infectious Diseases in Kenya, aiding in the treatment of HIV for thousands.
- Led numerous CDC and NIH-funded initiatives to enhance HIV care and treatment.
- Developed and directed the TREE program, focusing on innovative clinical trials related to HIV therapies.
- Conducted pioneering research on the use of oligonucleotide ligation assays (OLA) to detect drug resistance and improve ART strategies.
- Evaluated treatment methods for pre-cancerous cervical lesions in HIV-infected women, contributing vital data to the field.
- Investigating the mechanisms of chronic lung disease in HIV-infected adolescents, providing insight into this under-researched area.
